FDA Inspection
Hybrid Pharma LLCHybrid Pharma LLC – FDA Inspection, Nov 9, 2023
Record Details
This FDA Inspection record concerns Hybrid Pharma LLC, with an inspection on November 9, 2023, covering drugs.
- Company
- Hybrid Pharma LLC
- Inspection Date
- November 9, 2023
- Product Type
- Drugs
View Company Profile
ID · 4aa06683-906e-4099-a73c-5a091076a686
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1222392
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
11- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.42(c)(10)(i)Floors, walls, ceiling surfaces
- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.63Equipment Design, Size and Location
- FDCA 503B(a)(2)Bulk drug substances, cannot be used in compounding
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hybrid Pharma LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 3, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 20, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hybrid Pharma LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.